Patent · US Expired

On-site emergency treatment of injured or unconscious patients, using fructose-1,6-diphosphate (FDP)

US5910127A · kind A · utility

2Cited by
0References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 4, 1998
Grant dateJun 8, 1999
Priority date
Expiry dateJan 4, 2018

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07H11/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A method and device are disclosed which enable on-site pre-diagnostic emergency treatment of people suffering from life-threatening injuries (such as victims of auto accidents, shootings, stabbings, and near-drownings), or from a collapse or loss of consciousness that might be due to a heart attack, stroke, cardiac arrest, internal hemorrhage, or various other causes that cannot be diagnosed until after a physician or ambulance has arrived on the scene. This on-site pre-diagnostic emergency treatment involves intravenous injection of fructose-1,6-diphosphate (FDP, a naturally-occurring chemical which functions as an intermediate in glycolysis) into the patient. Such injections can be administered by police, firemen, military personnel, lifeguards, nursing home attendants, ambulance attendants, or anyone else who has been trained to administer intravenous injections. The FDP should be injected into the patient as soon as possible, without delaying until the patient can be diagnosed and treated by a doctor. When administered immediately, intravenously injected FDP can reduce ischemic or hypoxic damage to the internal organs, without having any adverse effects or posing any significan…

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.